Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle A Emmitte

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|June 20, 2023
Structure-Activity Relationship Study of the High-Affinity Neuropeptide Y<sub>4</sub> Receptor Positive Allosteric Modulator VU0506013Corinna Schüß, Oanh Vu, Nigam M Mishra, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure in ratsAndrew S Felts, Stacey R Lindsley, Jeffrey P Lamb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinasePeter Sabbatini, Jason L Rowand, Arthur Groy, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2018
Discovery of 6-(pyrimidin-5-ylmethyl)quinoline-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5Andrew S Felts, Alice L Rodriguez, Ryan D Morrison, et al.
Journal of Medicinal Chemistry|February 17, 2021
Highly Selective Y<sub>4</sub> Receptor Antagonist Binds in an Allosteric Binding PocketCorinna Schüß, Oanh Vu, Mario Schubert, et al.
British Journal of Cancer|November 3, 2018
Stress and interferon signalling-mediated apoptosis contributes to pleiotropic anticancer responses induced by targeting NGLY1Ashwini Zolekar, Victor J T Lin, Nigam M Mishra, et al.
Nucleic Acids Research|February 14, 2016
Targeting BRCA1- and BRCA2-deficient cells with RAD52 small molecule inhibitorsFei Huang, Nadish Goyal, Katherine Sullivan, et al.
Bioorganic & Medicinal Chemistry Letters|August 13, 2013
Octahydropyrrolo[3,4-c]pyrrole negative allosteric modulators of mGlu1Jason T Manka, Alice L Rodriguez, Ryan D Morrison, et al.
Molecular Cancer Therapeutics|February 3, 2007
In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1Timothy J Lansing, Randy T McConnell, Derek R Duckett, et al.
ACS Chemical Neuroscience|September 20, 2011
(3-Cyano-5-fluorophenyl)biaryl negative allosteric modulators of mGlu(5): Discovery of a new tool compound with activity in the OSS mouse model of addictionCraig W Lindsley, Brittney S Bates, Usha N Menon, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|June 20, 2023
Structure-Activity Relationship Study of the High-Affinity Neuropeptide Y<sub>4</sub> Receptor Positive Allosteric Modulator VU0506013Corinna Schüß, Oanh Vu, Nigam M Mishra, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure in ratsAndrew S Felts, Stacey R Lindsley, Jeffrey P Lamb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinasePeter Sabbatini, Jason L Rowand, Arthur Groy, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2018
Discovery of 6-(pyrimidin-5-ylmethyl)quinoline-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5Andrew S Felts, Alice L Rodriguez, Ryan D Morrison, et al.
Journal of Medicinal Chemistry|February 17, 2021
Highly Selective Y<sub>4</sub> Receptor Antagonist Binds in an Allosteric Binding PocketCorinna Schüß, Oanh Vu, Mario Schubert, et al.
British Journal of Cancer|November 3, 2018
Stress and interferon signalling-mediated apoptosis contributes to pleiotropic anticancer responses induced by targeting NGLY1Ashwini Zolekar, Victor J T Lin, Nigam M Mishra, et al.
Nucleic Acids Research|February 14, 2016
Targeting BRCA1- and BRCA2-deficient cells with RAD52 small molecule inhibitorsFei Huang, Nadish Goyal, Katherine Sullivan, et al.
Bioorganic & Medicinal Chemistry Letters|August 13, 2013
Octahydropyrrolo[3,4-c]pyrrole negative allosteric modulators of mGlu1Jason T Manka, Alice L Rodriguez, Ryan D Morrison, et al.
Molecular Cancer Therapeutics|February 3, 2007
In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1Timothy J Lansing, Randy T McConnell, Derek R Duckett, et al.
ACS Chemical Neuroscience|September 20, 2011
(3-Cyano-5-fluorophenyl)biaryl negative allosteric modulators of mGlu(5): Discovery of a new tool compound with activity in the OSS mouse model of addictionCraig W Lindsley, Brittney S Bates, Usha N Menon, et al.
Pageof 7